Abstract:Background. Baicalein has been used to treat inflammation‐related diseases; nevertheless, its specific mechanism of action is unclear. Therefore, we examined the protective effects of baicalein on lipopolysaccharide‐induced damage to AR42J pancreatic acinar cells (PACs) and determined its mechanism of action for protection. Methods. An in vitro cell model of acute pancreatitis (AP) was established using lipopolysaccharide (LPS) (1 mg/L)‐induced PACs (AR42J), and the relative survival rate was determined using the 3‐(4,5)‐dimethylthiahiazo(‐z‐y1)‐3,5‐di‐phenytetrazoliumromide (MTT) technique. Flow cytometry was applied to evaluate the apoptotic rates of AR42J PACs. The RNA and protein expression of miR‐224‐5p, poly ADP‐ribose polymerase‐1 (PARP1), nuclear transcription factor‐κB65 (NF‐κB65), phospho‐kappa B alpha(p‐IκB‐α), interleukin(IL)‐18R, NOD‐like receptor thermal protein domain‐associated protein 3 (NLRP3), gasdermin D (GSDMD), apoptosis‐associated speck‐like protein containing a CARD (ASC), and caspase‐1 was detected based on the WB and RT‐PCR assays. IL‐1β, IL‐6, IL‐18, and TNF‐α expression levels in AR42J cells were measured via ELISA method. The cell morphology was examined using the AO/EB method. Results. The experiment confirmed a significant increase in the activity of AR42J cells treated with various doses of baicalein. Moreover, IL‐1β, IL‐6, TNF‐α, and IL‐18 expression levels in AR42J cells were dramatically reduced (P < 0.05), while miR‐224‐5p level was obviously enhanced. The protein and gene expression of PARP1, NF‐κB65, p‐IκB‐α, IL‐18R, GSDMD, ASC, NLRP3, and caspase‐1 was obviously decreased (P < 0.05). Apoptosis in AR42J cells was significantly reduced with significant improvement in cell morphology. Conclusion. Baicalein may significantly alleviate LPS‐induced AR42J PAC damage by inhibiting the inflammatory response and pyroptosis. Its mode of action might be linked to higher miR‐224‐5p expression, which inhibits the PARP1/NF‐κB and NLPR3/ASC/caspase‐1/GSDMD pathways.

Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα pathway

Targeting inflammation‐associated <scp>AMPK</scp>//Mfn‐2/<scp>MAPKs</scp> signaling pathways by baicalein exerts anti‐atherosclerotic action

Targeting inflammation‐associated AMPK //Mfn‐2/ MAPKs signaling pathways by baicalein exerts anti‐atherosclerotic action

Baicalein reduces lipopolysaccharide-induced inflammation via suppressing JAK/STATs activation and ROS production

Baicalein suppresses lipopolysaccharide-induced acute lung injury by regulating Drp1-dependent mitochondrial fission of macrophages

Baicalin alleviates atherosclerosis by relieving oxidative stress and inflammatory responses via inactivating the NF-κB and p38 MAPK signaling pathways

Baicalein inhibits inflammatory and catabolic gene expression in interleukin-1 beta-induced human chondrocytes

Baicalein Inhibits MMPs Expression via a MAPK-Dependent Mechanism in Chondrocytes.

Baicalein attenuates the neuroinflammation in LPS-activated BV-2 microglial cells through suppression of pro-inflammatory cytokines, COX2/NF-κB expressions and regulation of metabolic abnormality

Anti-inflammatory activity of baicalein in LPS-stimulated RAW264.7 macrophages via estrogen receptor and NF-κB-dependent pathways

Protective Effects of Baicalein on Lipopolysaccharide‐Induced AR42J PACs through Attenuation of Both Inflammation and Pyroptosis via Downregulation of miR‐224‐5p/PARP1

Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF‑κB signaling pathway

Bacillus amyloliquefaciens Protect Against Atherosclerosis Through Alleviating Foam Cell Formation and Macrophage Polarization

Baicalin Modulates Inflammatory Response of Macrophages Activated by LPS via Calcium-CHOP Pathway

Baicalein exerts beneficial effects in lipopolysaccharide-induced pulmonary inflammation by modulating macrophage polarization and inhibiting pyroptosis

Baicalein Limits Osteoarthritis Development by Inhibiting Chondrocyte Ferroptosis.

Baicalein inhibits IL-1β-induced extracellular matrix degradation with decreased MCP-1 expression in primary rat chondrocytes

Baicalein suppresses inflammation and attenuates acute lung injury by inhibiting glycolysis via HIF‐1α signaling

Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice

Baicalein upregulates macrophage TREM2 expression via TrKB-CREB1 pathway to attenuate acute inflammatory injury in acute-on-chronic liver failure

Involvement of nuclear factor-kappaB in the inhibition of interleukin-12 production from mouse macrophages by baicalein, a flavonoid in Scutellaria baicalensis